Effects of glucocorticoids in ventilated piglets with severe pneumonia

European Respiratory Journal

Volumn 32, Issue 4, 2008, Pages 1037-1046

  Sibila, O ^a,b   Luna, C M ^c   Agusti C ^a,b   Baquero, S ^c   Gando, S ^c   Patron J R ^c   Morato, J G ^c   Absif, R ^c   Bassie, N ^c   Torres, A ^a,b,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Glucocorticoids; Inflammatory response; Piglets; Pseudomonas aeruginosa; Severe pneumonia; Ventilator associated pneumonia

Indexed keywords

C REACTIVE PROTEIN; CIPROFLOXACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; BODY BURDEN; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOMODULATION; INOCULATION; LUNG; LUNG FLUID; LUNG LAVAGE; LUNG PARENCHYMA; MONOTHERAPY; NONHUMAN; PIGLET; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PSEUDOMONAS AERUGINOSA; TISSUE CULTURE; TREATMENT RESPONSE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BRONCHOALVEOLAR LAVAGE; CIPROFLOXACIN; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; INFLAMMATION; LUNG; METHYLPREDNISOLONE; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RESPIRATION, ARTIFICIAL; SWINE; TIME FACTORS;

EID: 58849097182     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00009208     Document Type: Article

References (42)

1. Bodí M, Rodríguez A, Solé-Violán J, et al. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 2005; 41: 1709-1716.
2. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903.
3. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94: 281-288.
4. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159: 1249-1256.
5. Leeper KV, Torres A. Community-acquired pneumonia in the intensive care unit. Clin Chest Med 1995; 16: 155-171.
6. Montón C, Torres A, El Ebiary M, Filella X, Xaubert A, de la Bellacasa JP. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 1999; 27: 1745-1753.
7. Fernández-Serrano S, Dorca J, Coromines M, Carratala J, Gudiol F, Manresa F. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol 2003; 10: 813-820.
8. Ioanas M, Ferrer M, Cavalcanti M, et al. Causes and predictors of nonresponse to treatment of the intensive care unit-acquired pneumonia. Crit Care Med 2004; 32: 938-945.
9. Schutte H, Lohmeyer J, Rosseau S, et al. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996; 9: 1858-1867.
10. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995; 108: 1303-1314.
11. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 2005; 353: 1711-1723.
12. Monton C, Ewig S, Torres A, et al. Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. Eur Respir J 1999; 14: 218-220.
13. Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003; 167: 512-520.
14. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358: 111-124.
15. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998; 280: 159-165.
16. Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354: 1671-1684.
17. Meduri GU, Marik P, Chorousos GP, et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 2008; 34: 61-69.
18. Jantz MA, Sahn SA. Corticosteroids in acute respiratory failure. Am J Respir Crit Care Med 1999; 160: 1079-1100.
19. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005; 171: 242-248.
20. Marquette CH, Wermert D, Wallet F, Copin MC, Tonnel AB. Characterization of an animal model of ventilator-acquired pneumonia. Chest 1999; 115: 200-209.
21. Wermert D, Marquette CH, Copin MC, et al. Influence of pulmonary bacteriology and histology on the yield of diagnostic procedures in ventilator-acquired pneumonia. Am J Respir Crit Care Med 1998; 158: 139-147.
22. Goldstein I, Bughalo MT, Marquette CH, et al. Mechanical ventilation-induced air-space enlargement during experimental pneumonia in piglets. Am J Respir Crit Care Med 2001; 163: 958-964.
23. Goldstein I, Wallet F, Nicolas-Robin A, Ferrari F, Marquette CH, Rouby JJ. Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets. Am J Respir Crit Care Med 2002; 166: 1375-1381.
24. Elman M, Goldstein I, Marquette CH, et al. Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 2002; 97: 199-206.
25. Ferrari F, Goldstein I, Nieszkowszka A, et al. Lack of lung tissue and systemic accumulation after consecutive daily aerosols of amikacin in ventilated piglets with healthy lungs. Anesthesiology 2003; 98: 1016-1019.
26. Tonnellier M, Ferrari F, Goldstein I, Sartorius A, Marquette CH, Rouby JJ. Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen. Anesthesiology 2005; 102: 995-1000.
27. Luna CM, Baquero S, Gando S, et al. Experimental severe Pseudomonas aeruginosa pneumonia and antibiotic therapy in piglets receiving mechanical ventilation. Chest 2007; 132: 523-531.
28. Sibila O, Agustí C, Torres A, et al. Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response. Eur Respir J 2007; 30: 1167-1172.
29. Arancibia F, Bauer TT, Ewig S, et al. Community-acquired pneumonia due to Gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 2002; 162: 1849-1858.
30. Rossi A, Polese G, Brandi G, Conti G. Intrinsic positive end-expiratory pressure (PEEPi). Intensive Care Med 1995; 2: 522-536.
31. él-Ebiary M, Torres A, González J, et al. Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia. Am Rev Respir Dis 1993; 147: 1552-1557.
32. Balows A, Hausler WJJ. Manual of Clinical Microbiology. 5th Edn. Washington, American Society for Microbiology, 1991.
33. Marquette CH, Copin MC, Wallet F, et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995; 151: 1878-1888.
34. National Research Council. Guide for the Care and use of Laboratory Animals. Washington, National Academy Press, 1985.
35. Agustí C, Rañó A, Filella X, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response. Chest 2003; 123: 488-498.
36. Angrill J, Agustí C, De Celis R, et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001; 164: 1628-1632.
37. Meduri GU, Kanangat S, Bronze M, et al. Effects of methylprednisolone on intracellular bacterial growth. Clin Diagn Lab Immunol 2001; 8: 1156-1163.
38. Craven DE, Duncan RA. Preventing ventilator-associated pneumonia: tiptoeing through a minefield. Am J Respir Crit Care Med 2006; 173: 1297-1298.
39. Lefering R, Neugebauer EM. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995; 23: 1294-1303.
40. Herrige MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Eng J Med 2003; 348: 683-693.
41. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired on the intensive care unit: a prospective multicenter study. JAMA 2002; 288: 2859-2867.
42. Wolthius EK, Choi G, Dessing MC, et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents pulmonary inflammation in patients without preexisting lung injury. Anesthesiology 2008; 108: 46-54.